4//SEC Filing
Biniszkiewicz Detlev 4
Accession 0001209191-22-001339
CIK 0001808865other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:41 PM ET
Size
12.2 KB
Accession
0001209191-22-001339
Insider Transaction Report
Form 4
Biniszkiewicz Detlev
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-01-03−3,500→ 13,108 totalExercise: $19.00From: 2021-06-16Exp: 2030-07-23→ Common Stock (3,500 underlying) - Exercise/Conversion
Common Stock
2022-01-03$19.00/sh+3,500$66,500→ 3,500 total - Sale
Common Stock
2022-01-03$51.90/sh−3,500$181,650→ 0 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816317
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:41 PM ET
- Size
- 12.2 KB